Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial
| Autor: | Zinman, Bernard, Fulcher, Greg, Rao, Paturi V, Thomas, Nihal, Endahl, Lars A, Johansen, Thue, Lindh, Rebecka, Lewin, Andrew, Rosenstock, Julio, Pinget, Michel, Mathieu, Chantal |
|---|---|
| Zdroj: | In The Lancet 2011 377(9769):924-931 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|